✦ LIBER ✦

P994 GLUT-1 as a biomarker for epithelial ovarian cancer

✍ Scribed by Jeon, Y.; Cho, H.; Chay, D.; Lee, H.; Kim, J.

Book ID: 122287951
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 47 KB
Volume: 107
Category: Article
ISSN: 0020-7292
DOI: 10.1016/S0020-7292(09)62481-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Utility of osteopontin as a biomarker in

Utility of osteopontin as a biomarker in recurrent epithelial ovarian cancer

✍ K.A Brakora; H Lee; R Yusuf; L Sullivan; A Harris; T Colella; M.V Seiden 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 185 KB

Emerging role of inhibin as a biomarker

Emerging role of inhibin as a biomarker for ovarian cancer

✍ Robertson, David M; Oehler, Martin K 📂 Article 📅 2005 🏛 Future Medicine 🌐 English ⚖ 114 KB

Mean platelet volume could be a useful b

Mean platelet volume could be a useful biomarker for monitoring epithelial ovarian cancer

✍ Kemal, Y.; Demirağ, G.; Ekiz, K.; Yücel, İ. 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 208 KB

HE4 as a biomarker for ovarian and endom

HE4 as a biomarker for ovarian and endometrial cancer management

✍ Li, Jinping; Dowdy, Sean; Tipton, Tracy; Podratz, Karl; Lu, Wei-Guo; Xie, Xing; 📂 Article 📅 2009 🏛 Expert Reviews 🌐 English ⚖ 332 KB

LINE-1 hypomethylation level as a potent

LINE-1 hypomethylation level as a potential prognostic factor for epithelial ovarian cancer

✍ J. PATTAMADILOK; N. HUAPAI; P. RATTANATANYONG; A. VASURATTANA; S. TRIRATANACHAT; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

Autoantibodies against stress-induced ph

Autoantibodies against stress-induced phosphoprotein-1 as a novel biomarker candidate for ovarian cancer

✍ Sunghoon Kim; HanByoul Cho; Eun Ji Nam; Sang Wun Kim; Young Tae Kim; Yong Won Pa 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 383 KB

## Abstract Detection of autoantibodies against tumor‐associated antigens (TAA) has recently been shown to be a powerful tool for early detection of various cancers. The aim of this study was to investigate the possibility of using autoantibodies against TAA as novel biomarkers by a proteomics‐base